Upcoming webinars in June
ALS, Chromatin Research, Proteomics
In times of contact restrictions and limited freedom to travel, online webinars are a great way to learn more and stay in touch with professional colleagues. Together with our partners and experts from diverse fields, we regularly present you upcoming webinars of interest. Have a look what is in for you in june.
The ALS-Reproducible Antibody Platform (ALS-RAP): Identification of high-quality antibodies for ALS research
Presented by GeneTex
Date: Tuesday, 8th June, at 05:00 pm (CEST)
Speaker: Dr. Carl Laflamme, McGill University’s Montreal Neurological Institute
GeneTex is honored to host Dr. Carl Laflamme, a senior postdoctoral research fellow in the laboratory of the distinguished Dr. Peter McPherson at McGill University’s Montreal Neurological Institute. Dr. Laflamme’s work has focused on understanding the mechanisms underlying amyotrophic lateral sclerosis (ALS) with particular emphasis on C9orf72, a gene whose disruption represents the most common genetic cause of ALS/frontotemporal dementia (FTD). In addition, he is currently spearheading the ALS Reproducible Antibody Platform (ALS-RAP) that is dedicated to leveraging CRISPR/Cas9 knockout technology to identify reliable commercial antibodies for ALS/FTD research.
In his talk, Dr. Laflamme will discuss his published work describing the systematic assessment of antibodies against the C9ORF72 protein as part of ALS-RAP. He will then present intriguing data regarding C9ORF72 biology in macrophages, and will introduce his very exciting and potentially revolutionary efforts to expand the ALS-RAP methodology for antibodies against additional ALS disease proteins as well as those of other neurodegenerative disorders. Dr. Laflamme will explain how this approach will be further broadened and amplified to address the commercial antibody reliability crisis in biomedical research.
SARS-CoV-2 Serology Testing by Flow Cytometry
Presented by Immunostep
Date: Thursday, 10th June, at 02:00 pm (CEST)
Understand how a serological assay by flow cytometry works allowing us to detect 3 immunoglobulins against 4 viral proteins simultaneously.
Watch online and live how this serological assay offers the information about how the antibodies were generated: by natural infection or as a result of the vaccination.
Round of questions: Open a talk about the needs and opportunities this assay can offer to understand serological testing performance.
CUT&Tag and ChIP-Seq: How to synergize your chromatin research?
Presented by Active Motif
Date: Wednesday, 16th June, at 11:00 am (CEST)
In this seminar we will discuss how CUT&Tag and ChIP-Seq can be utilized together to improve your chromatin research and give a detailed overview of our novel tools, instruments, and end-to-end services.
We will also discuss a series of data generated by our scientists for drug discovery and human disease research and cover our approach to support the generation and integration of “EpiOmics” datasets. Following the presentation, there will be a “round table” session where all your questions and feedback will be covered.
The importance of monitoring calprotectin on a regular basis
Presented by Svar Calpro
Date: Thursday, 17th June, at 09:00 am (CEST)
Speaker: Mr. Charlie Lees, Professor of Gastroenterology, Western General Hospital, Edinburgh and Senior Lecturer at the University of Edinburgh, Scotland
Did you know that Calpro’s solutions for measuring calprotectin may help shape the future for IBD patients?
Our Key Speaker, Prof. Charlie Lees, has used the Calpro Elisa assay in his lab for approximately 15 years and the results have given him and his team a large database of useful information. In addition, Charlie has a deep interest in studying environmental factors that have an impact on the development of IBD.
In this webinar, presented by Line Tommerup, Country Manager DK & Project Manager International eHealth / Pharma Projects at Calpro, we get the opportunity to learn more about Charlie Lees’ work and his view on how data can be used to shape the treatment of IDB in future.
Key Learning Objectives
- The importance of monitoring calprotectin with regular intervals
- How data can help us to start tackle IBD
- The importance of digital tools
Recorded webinars from the past are to find in our scientific content area.